Gene Expression and Serum Cytokine Profiling of Low Stage CLL Identify WNT/PCP, Flt-3L/Flt-3, and CXCL9/CXCR3 as Regulators of Cell Proliferation, Survival, and Migration. (21st May 2009)

• Record Type: Journal Article
• Authors: Mahadevan, Daruka; Choi, James; Cooke, Laurence; Simons, Bram; Riley, Christopher; Klinkhammer, Thomas; Sud, Rohit; Maddipoti, Sirisha; Hehn, Sean; Garewal, Harinder; Spier, Catherine
• Other Names: Ferguson Lynnette R. Academic Editor.
• Is Part Of: Human genomics and proteomics. Volume 2009(2009)
• Publication Date: 2009-05-21
• Subjects: Human genome -- Periodicals; Genomics -- Periodicals; Genetics -- Research -- Periodicals; Pharmacogenetics -- Periodicals; Proteomics -- Periodicals; Proteins -- Periodicals; 611.01816
• DOI: 10.4061/2009/453634
• Languages: English
• ISSNs: 1757-4242

Abstract

Abstract : Gene expression profiling (GEP) of 8 stage 0/I untreated Chronic Lymphocytic Leukemia (CLL) patients showed over-expression of Frizzled 3 (FZD3)/ROR-1 receptor tyrosine kinase (RTK), FLT-3 RTK and CXCR3 G-protein coupled receptor (GPCR). RT-PCR of 24 genes in 21 patients of the WNT pathway corroborated the GEP. Transforming growth factorβ, fibromodulin, TGFβ RIII and SMAD2 are also over-expressed by GEP. Serum cytokine profiling of 26 low stage patients showed elevation of IFNγ, CSF3, Flt-3L and insulin-like growth factor binding protein 4. In order to ascertain why CLL cells grow poorly in culture, a GEP of 4 CLL patients cells at 0 hr and 24 hr in culture demonstrated over expression of CXCL5, CCL2 and CXCL3, that may recruit immune cells for survival. Treatment with thalidomide, an immunomodulatory agent, showed elevation of CCL5 by GEP but was not cytotoxic to CLL cells. Our data suggest an interplay of several oncogenic pathways, cytokines and immune cells that promote a survival program in CLL.